RSS   Newsletter   Contact   Advertise with us

Korea begins preliminary review of AstraZeneca's coronavirus vaccine candidate

Christian Fernsby ▼ | October 27, 2020
South Korea's food and drug ministry said on Tuesday it had begun a preliminary review of a coronavirus vaccine being developed by AstraZeneca PLC for potential fast track approval.
AstraZeneca
Korea   AstraZeneca
The Ministry of Food and Drug Safety said in a statement that it had formed a screening team to review the vaccine candidate, with an application for formal approval expected in 90 days under its rapid approval programme for coronavirus treatments and vaccines.

Topics: AstraZeneca

The team is reviewing the vaccine's non-clinical test data, the ministry said.

The ministry added that it had given a green light to some 26 clinical trials for coronavirus treatments and vaccines as of Monday, by entities such as pharmaceutical companies Celltrion Inc and Genexine Inc, with seven completed and 19 ongoing.


 

MORE INSIDE POST